Balonix®med, chewable tablets is indicated for the symptomatic treatment of digestive disorders accompanied by excessive gas accumulation in the abdomen, the prevention of abdominal gas formation and the preparation of abdominal examinations for diagnostic purposes
• chewable tablets immediately release the functional ingredient, which ensures a rapid effect
• simeticone acts strictly at the intestinal level where it prevents the formation of gas bubbles
• simeticone has a physical mechanism of action and is not absorbed from the digestive tract
calms and prevents bloating and flatulence
eliminates abdominal discomfort
pleasant taste
Balonix®med, chewable tablets is indicated for:
symptomatic treatment of gas-related gastrointestinal disorders in order to relieve the clinical symptoms such as bloating, meteorism, belching and abdominal tension;
prevention of excessive formation of abdominal gases, after surgical interventions;
preparation for diagnostic abdominal explorations such as: radiography, radioscopy, ultrasound, gastroduodenoscopy and colonoscopy facilitating abdominal medical examination
Simeticone corresponding to 80 mg dimethicone/tablet
The other components are: sorbitol, silicon dioxide, polyvinylpyrrolidone, magnesium stearate, talc, lemon flavor
Balonix®med, chewable tablets contains simeticone as functional ingredient, which is a stable mixture of dimethicone and silicone dioxide with surface activity. Simeticone alters the surface tension of the gas bubbles embedded in bolus and mucous of the digestive tract, therefore these bubbles are disintegrated. The gases released in this process can be absorbed by the intestinal wall, and therefore are eliminated
through intestinal peristalsis. Simeticone acts strictly on gastrointestinal tract only by physical mechanism, not being absorbed into
body. Simeticone is not involved in chemical reactions and is pharmacologically and physiologically inert.
symptomatic treatment of gas-related gastrointestinal disorders:
Children 6 – 14 years: 1 chewable tablet, 2 – 3 times a day
Adolescents and adults: 1 – 2 chewable tablets, 3 – 4 times a day
The tablets should be taken during or after meals and also at bedtime, if necessary. Duration of the treatment depends on the symptom’s evolution. Consult your physician if the symptoms do not improve within 7 days of treatment.
Balonix®med, chewable tablets cannot be used for a period longer than 30 consecutive days.
preparation for diagnostic abdominal explorations: the usual dose is 2 – 5 chewable tablets in the day before the examination and 1 – 2 chewable tablets in the morning of examination